Fundraising Fox

AltheaDx

San Diego, US · Delaware corporation · 4 known investors

Biotech

Founders & leadership

FF
Francois FerreCo-founder
MM
Magda MarquetCo-founder
JG
Jorge GarcesinCEOformer
GH
Greg HamiltonExecutive
CS
Carin SandvikExecutive
JG
Jeffrey G. BlackExecutive

Board

JL
Jason LiuBoard director
YT
Yuh-geng TsayBoard directorVenture Partner at Vivo Capital
AK
Ann KesslerBoard director
DN
David NikodemBoard director
WL
Wei LiBoard director
JM
J. Matthew MackowskiBoard director

Investors · 4

BioBritLa Jolla
Ally Bridge GroupreportedNew York
Vivo CapitalreportedPalo Alto · $10M – $50Mvia Yuh-geng Tsay · board
WuXi Healthcare VenturesreportedGrand Cayman

Reported raises · per SEC filings

Form D private placements

$41M disclosed across 10 rounds · 2014–2020

▶$3.7MraisedDec 2020 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francois FerreDirector
  • David NikodemExecutive Officer, Director
  • Feng CaoExecutive Officer
Offering amount
$6.2M
Amount sold
$3.7M
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francois FerreDirector
  • Wei LiDirector
  • David NikodemExecutive Officer, Director
  • John WuDirector
  • Yuh-geng TsayDirector
  • Feng CaoExecutive Officer
Offering amount
$1.7M
Amount sold
$1.3M
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.7MraisedJan 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wei LiDirector
  • David NikodemExecutive Officer, Director
  • Yuh-geng TsayDirector
  • Feng CaoExecutive Officer
  • Francois FerreDirector
  • John WuDirector
Offering amount
$5M
Amount sold
$1.7M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Francois FerreDirector
  • David NikodemDirector
  • Yuh-geng TsayDirector
  • Feng CaoExecutive Officer
  • John WuDirector
  • Wei LiExecutive Officer, Director
Offering amount
$5M
Amount sold
$2M
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$830.6KraisedMar 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wei LiExecutive Officer, Director
  • John WuDirector
  • Francois FerreDirector
  • Yuh-geng TsayDirector
  • Andrew JacksonExecutive Officer
  • David NikodemDirector
Offering amount
$3M
Amount sold
$830.6K
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ann KesslerDirector
  • John WuDirector
  • Jorge GarcesExecutive Officer, Director
  • Andrew JacksonExecutive Officer
  • Yuh-geng TsayDirector
  • Francois FerreDirector
  • Jason LiuDirector
  • Wei LiDirector
  • David NikodemDirector
Offering amount
$15M
Amount sold
$3M
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedSep 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jorge GarcesExecutive Officer, Director
  • Wei LiDirector
  • Jason LiuDirector
  • David NikodemDirector
  • Yuh-geng TsayDirector
  • Ann KesslerDirector
  • Francois FerreDirector
Offering amount
$6M
Amount sold
$6M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJul 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jorge GarcesExecutive Officer, Director
  • Jason LiuDirector
  • Ann KesslerDirector
  • Francois FerreDirector
  • Yuh-geng TsayDirector
  • Wei LiDirector
  • David NikodemDirector
Offering amount
$6M
Amount sold
$2.2M
First sale
Jul 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through AltheaDx went on to found or lead other companies.

Laurie HeilmannStrategic Advisory Board, Corporate DevelopmentFounded NotableDaniel BradburyDirectorFounded Sensulin

In the news

Castle Biosciences to Acquire AltheaDx | AZBioazbio.org · Apr 2022San Diego California based AltheaDx is raising $6,212,720.00 in Equity Investment. - intelligence360intelligence360.news · Dec 2020AltheaDx Inc. Raises $27 Million in Series D Funding - San Diego Business Journalsdbj.com · Apr 2017AltheaDx Closes $27M Series D Funding - FinSMEsfinsmes.com · Apr 2017BioCentury - AltheaDx raises $30M in series Cbiocentury.com · Dec 2015AltheaDx Closes $30M Series C Financing Round | GenomeWebgenomeweb.com · Dec 2015

Frequently asked questions

Who founded AltheaDx?
AltheaDx was founded by Francois Ferre, Magda Marquet.
Who are AltheaDx's investors?
AltheaDx's investors include BioBrit, Ally Bridge Group, Vivo Capital, WuXi Healthcare Ventures.
How much funding has AltheaDx raised?
AltheaDx has disclosed $41M raised across 10 rounds.
Where is AltheaDx headquartered?
AltheaDx is headquartered in San Diego, US.